| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID217314 | Binding affinity for Vitronectin receptor (alpha V beta 3) | 2000 | Journal of medicinal chemistry, Jan-13, Volume: 43, Issue:1
| Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. |
| AID29071 | Half life period in rat | 2000 | Journal of medicinal chemistry, Jan-13, Volume: 43, Issue:1
| Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. |
| AID220876 | Inhibition of integrin alphaIIb-beta3 in platelet aggregation assay | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Binding model for nonpeptide antagonists of alpha(v)beta(3) integrin. |
| AID217306 | Inhibition of binding to human Vitronectin receptor (integrin alphaV-beta3) | 2003 | Journal of medicinal chemistry, Dec-04, Volume: 46, Issue:25
| Molecular model of the alpha(IIb)beta(3) integrin. |
| AID82356 | HEK cell adhesion mediated by alpha v beta 3 integrin | 2000 | Journal of medicinal chemistry, Jan-13, Volume: 43, Issue:1
| Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. |
| AID217313 | Inhibition of Vitronectin receptor, integrin alphaV-beta3 expressed in HEK 293 cells | 2002 | Journal of medicinal chemistry, Dec-19, Volume: 45, Issue:26
| Binding model for nonpeptide antagonists of alpha(v)beta(3) integrin. |
| AID32990 | Inhibition of human alphaIIb-beta3 integrin in platelet aggregation assay | 2003 | Journal of medicinal chemistry, Dec-04, Volume: 46, Issue:25
| Molecular model of the alpha(IIb)beta(3) integrin. |
| AID27902 | Plasma clearance in rat | 2000 | Journal of medicinal chemistry, Jan-13, Volume: 43, Issue:1
| Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. |
| AID29434 | Oral bioavailability in rat | 2000 | Journal of medicinal chemistry, Jan-13, Volume: 43, Issue:1
| Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. |
| AID220880 | Binding affinity for alpha IIb beta-3 integrin | 2000 | Journal of medicinal chemistry, Jan-13, Volume: 43, Issue:1
| Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |